Development Status and Prospects of the Guidance System for Rare Disease Drugs in China
Sha Mingquan, Sun Tanlin, Lu Jian, Xia Wenjing, Liu Dan, Bai Yu
Chinese Pharmaceutical Affairs . 2026, (8): 890 -897 .  DOI: 10.16153/j.1002-7777.2025-11-0054

京ICP备17052540号-7
Copyright © Chinese Pharmaceutical Affairs, All Rights Reserved.
Powered by Beijing Magtech Co. Ltd.